Physiogenex will be presenting its 3-week ultra-fast NASH screening mouse model mouse at the Liver Meeting 2018, in San Francisco, November 9th-13th, 2018.
The effects of GLP-1 receptor agonists in this innovative NASH mouse model will be presented by Dr. François Briand, Director of Research and Business Development, during the poster session on Sunday, November 11th, 12:30am-2:00pm, poster#1827.
If you want to set an appointment during the Liver Meeting with Dr. François Briand to discuss about your NASH projects, please contact us !